Aperam S.A. (AMS:APAM)
Netherlands · Delayed Price · Currency is EUR | Market Cap | 3.29B +71.4% |
| Revenue (ttm) | 6.03B -3.9% |
| Net Income | 127.00M -33.9% |
| EPS | 1.75 -33.4% |
| Shares Out | 72.46M |
| PE Ratio | 25.94 |
| Forward PE | 13.29 |
| Dividend | 1.70 (3.74%) |
| Ex-Dividend Date | Aug 13, 2026 |
| Volume | 158,462 |
| Open | 45.46 |
| Previous Close | 45.20 |
| Day's Range | 44.64 - 46.18 |
| 52-Week Range | 24.32 - 53.85 |
| Beta | 1.82 |
| Analysts | Hold |
| Price Target | 51.20 (+12.43%) |
| Earnings Date | Jul 30, 2026 |
About Aperam
Aperam S.A., together with its subsidiaries, produces and sells stainless steel and alloy products worldwide. The company operates through four segments: Stainless & Electrical Steel; Services & Solutions; Alloys & Specialties; and Recycling & Renewables. The company offers a range of stainless steel, flat stainless and electrical steel, and special carbon products. It also produces specialty grades alloys and specialties. In addition, the company engages in tubes business, as well as provision of value added and customized steel solutions. Fur... [Read more]
Financial Performance
In 2025, Aperam's revenue was 6.08 billion, a decrease of -2.80% compared to the previous year's 6.26 billion. Earnings were 9.00 million, a decrease of -96.10%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for APAM stock is "Hold." The 12-month stock price target is €51.20, which is an increase of 12.43% from the latest price.
News
Aperam Earnings Call Transcript: Q2 2026
Q2 2026 saw robust EBITDA of EUR 130 million, driven by transformation and margin focus, with positive legal impacts in Brazil and ongoing investments in Europe and Brazil. Outlook for Q3 is seasonally muted, with stronger demand expected in Q4.
Aperam Slides: Q2 2026
Aperam has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Aperam Earnings release: Q2 2026
Aperam released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Aperam Quarterly report: Q2 2026
Aperam has published its Q2 2026 quarterly earnings report on July 30, 2026.
Aperam Earnings Call Transcript: Q2 2026
Q2 2026 delivered the strongest results in four years, with EBITDA up 77% sequentially and all segments contributing meaningfully. Despite macro headwinds and energy volatility, strategic transformation and cost discipline drove robust cash flow, reduced debt, and reinforced long-term growth targets.
Aperam Earnings release: Q2 2026
Aperam released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.
Aperam Slides: Q2 2026
Aperam has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 30, 2026.
Aperam Quarterly report: Q2 2026
Aperam has published its Q2 2026 quarterly earnings report on July 30, 2026.
Aperam price target raised to EUR 46.10 from EUR 42.70 at JPMorgan
JPMorgan analyst Dominic O’Kane raised the firm’s price target on Aperam (APEMY) to EUR 46.10 from EUR 42.70 and keeps a Neutral rating on the shares.
Aperam downgraded to Underperform from Neutral at BNP Paribas
BNP Paribas analyst Tristan Gresser downgraded Aperam (APEMY) to Underperform from Neutral with a price target of EUR 38, up from EUR 36.
Aperam downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley downgraded Aperam (APEMY) to Equal Weight from Overweight with a price target of EUR 52, up from EUR 48. While the European stainless structural reset remains intact, supported…
Aperam price target raised to EUR 50 from EUR 42 at Citi
Citi raised the firm’s price target on Aperam (APEMY) to EUR 50 from EUR 42 and keeps a Neutral rating on the shares.
Aperam price target raised to EUR 63 from EUR 62 at Deutsche Bank
Deutsche Bank analyst Bastian Synagowitz raised the firm’s price target on Aperam (APEMY) to EUR 63 from EUR 62 and keeps a Buy rating on the shares. Published first on…
Aperam price target raised to EUR 42.70 from EUR 40.70 at JPMorgan
JPMorgan analyst Dominic O’Kane raised the firm’s price target on Aperam (APEMY) to EUR 42.70 from EUR 40.70 and keeps a Neutral rating on the shares.
Aperam Earnings Call Transcript: Q1 2026
European stainless operations saw improved utilization and margin expansion in Q1 2026, driven by reduced imports and restocking, while underlying demand remains weak. Guidance for 2028 EBITDA is EUR 700–800 million, with further upside from CapEx initiatives.
Aperam Quarterly report: Q1 2026
Aperam has published its Q1 2026 quarterly earnings report on April 30, 2026.
Aperam Slides: Q1 2026
Aperam has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Aperam Earnings Call Transcript: Q1 2026
Q1 2026 delivered the best start in three years, with EBITDA up 34% quarter-on-quarter and all segments contributing. Outlook for Q2 is even stronger, driven by Brazil's seasonal uplift and European trade defense, while strategic investments and acquisitions support long-term growth.
Aperam Quarterly report: Q1 2026
Aperam has published its Q1 2026 quarterly earnings report on April 30, 2026.
Aperam Slides: Q1 2026
Aperam has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 30, 2026.
Aperam price target raised to EUR 42 from EUR 37 at Citi
Citi analyst Krishan Agarwal raised the firm’s price target on Aperam (APEMY) to EUR 42 from EUR 37 and keeps a Neutral rating on the shares.
Aperam upgraded to Buy from Hold at Jefferies
Jefferies upgraded Aperam (APEMY) to Buy from Hold with a EUR 47 price target The firm note the derating in the stock following Iran war escalation, adding that given the…
Aperam price target raised to EUR 63 from EUR 62 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Aperam (APEMY) to EUR 63 from EUR 62 and keeps a Buy rating on the shares.
Aperam Earnings release: Q1 2026
Aperam released its Q1 2026 earnings on April 2, 2026, summarizing the period's financial results.
Aperam downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Dominic O’Kane downgraded Aperam (APEMY) to Neutral from Overweight with a price target of EUR 40.70, down from EUR 45.10. The firm says events in the Middle East…